Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Am J Psychiatry

Retrieve available abstracts of 34 articles:
HTML format

Single Articles

    February 2022
  1. GRABSKI M, McAndrew A, Lawn W, Marsh B, et al
    Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder.
    Am J Psychiatry. 2022;179:152-162.
    PubMed     Abstract available

    January 2022
  2. KRANZLER HR, Zhou H, Kember RL
    Identifying and Reducing Bias in Genome-Wide Association Studies of Alcohol-Related Traits.
    Am J Psychiatry. 2022;179:14-16.

    Alcohol and Cannabis Use Disorders.
    Am J Psychiatry. 2022;179:1-4.

  4. MELLENTIN AI, Mejldal A, Guala MM, Stoving RK, et al
    The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study.
    Am J Psychiatry. 2022;179:46-57.
    PubMed     Abstract available

  5. BROWNE KC, Stohl M, Bohnert KM, Saxon AJ, et al
    Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III).
    Am J Psychiatry. 2022;179:26-35.
    PubMed     Abstract available

  6. MALLARD TT, Savage JE, Johnson EC, Huang Y, et al
    Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts.
    Am J Psychiatry. 2022;179:58-70.
    PubMed     Abstract available

    September 2021
    Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
    Am J Psychiatry. 2021;178:779-782.

  8. PRISCIANDARO JJ, Hoffman M, Brown TR, Voronin K, et al
    Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial.
    Am J Psychiatry. 2021;178:829-837.
    PubMed     Abstract available

    June 2021
    COVID-19 and Stress-Related Disorders.
    Am J Psychiatry. 2021;178:471-474.

  10. RAY LA, Green R, Grodin E
    Neurobiological Models of Alcohol Use Disorder in Humans.
    Am J Psychiatry. 2021;178:483-484.

  11. KING A, Vena A, Hasin DS, deWit H, et al
    Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder.
    Am J Psychiatry. 2021;178:560-571.
    PubMed     Abstract available

    May 2021
  12. MASON BJ
    Medications to Treat Alcohol Use Disorder: Targeting the Dark Side.
    Am J Psychiatry. 2021;178:375-377.

    January 2021
  13. SHMULEWITZ D, Aharonovich E, Witkiewitz K, Anton RF, et al
    The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.
    Am J Psychiatry. 2021 Jan 21:appiajp202020050610.
    PubMed     Abstract available

    November 2020
  14. SINHA R, Wemm S, Fogelman N, Milivojevic V, et al
    Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Am J Psychiatry. 2020 Nov 19:appiajp202020050609.
    PubMed     Abstract available

  15. KOOB GF, Powell P, White A
    Addiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19.
    Am J Psychiatry. 2020;177:1031-1037.

    Why Timing Matters in Alcohol Use Disorder Recovery.
    Am J Psychiatry. 2020;177:1022-1024.

  17. EVANS-POLCE RJ, Kcomt L, Veliz PT, Boyd CJ, et al
    Alcohol, Tobacco, and Comorbid Psychiatric Disorders and Associations With Sexual Identity and Stress-Related Correlates.
    Am J Psychiatry. 2020;177:1073-1081.
    PubMed     Abstract available

  18. BLAINE SK, Wemm S, Fogelman N, Lacadie C, et al
    Association of Prefrontal-Striatal Functional Pathology With Alcohol Abstinence Days at Treatment Initiation and Heavy Drinking After Treatment Initiation.
    Am J Psychiatry. 2020;177:1048-1059.
    PubMed     Abstract available

    September 2020
  19. SPAGNOLO PA, Montemitro C, Leggio L
    New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol and Substance Use Disorders-The Perfect Storm.
    Am J Psychiatry. 2020;177:805-807.

    July 2020
  20. HASIN DS
    Alcohol Use Disorder and Suicide Risk: A Fresh and Closer Look.
    Am J Psychiatry. 2020;177:572-573.

  21. EDWARDS AC, Ohlsson H, Sundquist J, Sundquist K, et al
    Alcohol Use Disorder and Risk of Suicide in a Swedish Population-Based Cohort.
    Am J Psychiatry. 2020;177:627-634.
    PubMed     Abstract available

    February 2020
  22. MATHEW SJ, Price RB
    Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring Change.
    Am J Psychiatry. 2020;177:107-109.

  23. DAKWAR E, Levin F, Hart CL, Basaraba C, et al
    A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial.
    Am J Psychiatry. 2020;177:125-133.
    PubMed     Abstract available

    September 2019
  24. KWAKO LE, Schwandt ML, Ramchandani VA, Diazgranados N, et al
    Neurofunctional Domains Derived From Deep Behavioral Phenotyping in Alcohol Use Disorder.
    Am J Psychiatry. 2019;176:744-753.
    PubMed     Abstract available

    May 2019
  25. KENDLER KS, Ohlsson H, Sundquist J, Sundquist K, et al
    Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample.
    Am J Psychiatry. 2019 May 6:appiajp201918101217.
    PubMed     Abstract available

    March 2019
  26. HEIFETS BD, Williams NR, Blasey C, Sudheimer K, et al
    Target Population, Dose, and Timing Considerations for Understanding Naltrexone's Subjective Effect: Response to Amiaz.
    Am J Psychiatry. 2019;176:251-252.

    February 2019
  27. KLEINMAN RA, Ostacher MJ
    Prazosin and Alcohol Use Disorder.
    Am J Psychiatry. 2019;176:165.

  28. SIMPSON TL, Saxon AJ, Raskind M
    Prazosin for Alcohol Use Disorder: Response to Kleinman and Ostacher.
    Am J Psychiatry. 2019;176:165-166.

  29. POLLOCK JD, Lossie AC
    Phenotype and Environment Matter: Discovering the Genetic and Epigenetic Architecture of Alcohol Use Disorders.
    Am J Psychiatry. 2019;176:92-95.

  30. KALIN NH
    New Findings Relevant to Substance Use Disorders.
    Am J Psychiatry. 2019;176:A10.

  31. MACKEY S, Allgaier N, Chaarani B, Spechler P, et al
    Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects.
    Am J Psychiatry. 2019;176:119-128.
    PubMed     Abstract available

  32. SANCHEZ-ROIGE S, Palmer AA, Fontanillas P, Elson SL, et al
    Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts.
    Am J Psychiatry. 2019;176:107-118.
    PubMed     Abstract available

    January 2019
    Use of Disulfiram for Treatment of Alcohol Addiction in Patients With Psychotic Illness.
    Am J Psychiatry. 2019;176:80-81.

    November 2018
  34. EDWARDS AC, Ohlsson H, Svikis DS, Sundquist J, et al
    Protective Effects of Pregnancy on Risk of Alcohol Use Disorder.
    Am J Psychiatry. 2018 Nov 29:appiajp201818050632.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alcoholism is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.